Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation

C. Yim, I. Dijkgraaf, R. Merkx, C. Versluis, A. Eek, G. Mulder, D. Rijkers, O. Boerman and R. Liskamp

(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases

R. Gilles, W. Vogel, C. Gidding, G. Janssens, T. van der Vliet and W. Oyen

[Radiogenic nephropathy]

M. Gotthardt

Beta cell imaging--why we need it and what has been achieved

M. Gotthardt

Nodular fasciitis on F-18 FDG PET

M. Gotthardt, A. Arens, E. van der Heijden, L. de Geus-Oei and W. Oyen

Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody

F. Aarts, O. Boerman, R. Sharkey, T. Hendriks, C. Chang, W. McBride, R. Bleichrodt, W. Oyen and D. Goldenberg

Approaches for imaging islets: recent advances and future prospects

U. Ahlgren and M. Gotthardt

Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome

A. Rennings, P. Meijer, D. van Uden, C. Tack, P. Smits, O. Boerman, W. Oyen and G. Rongen

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues

E. Rolleman, M. Melis, R. Valkema, O. Boerman, E. Krenning and M. de Jong

Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation

S. Roosenburg, P. Laverman, L. Joosten, A. Eek, W. Oyen, M. de Jong, F. Rutjes, F. van Delft and O. Boerman

ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model

S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, G. Franssen, Y. Versleijen-Jonkers, W. Oyen, W. van der Graaf and O. Boerman

Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice

R. Schoffelen, W. van der Graaf, G. Franssen, R. Sharkey, D. Goldenberg, W. McBride, E. Rossi, A. Eek, W. Oyen and O. Boerman

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors

B. Hoeben, J. Kaanders, G. Franssen, E. Troost, P. Rijken, E. Oosterwijk, G. van Dongen, W. Oyen, O. Boerman and J. Bussink

Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts

R. Schoffelen, R. Sharkey, D. Goldenberg, G. Franssen, W. McBride, E. Rossi, C. Chang, P. Laverman, J. Disselhorst, A. Eek, W. van der Graaf, W. Oyen and O. Boerman

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

R. Boellaard, M. O'Doherty, W. Weber, F. Mottaghy, M. Lonsdale, S. Stroobants, W. Oyen, J. Kotzerke, O. Hoekstra, J. Pruim, P. Marsden, K. Tatsch, C. Hoekstra, E. Visser, B. Arends, F. Verzijlbergen, J. Zijlstra, E. Comans, A. Lammertsma, A. Paans, A. Willemsen, T. Beyer, A. Bockisch, C. Schaefer-Prokop, D. Delbeke, R. Baum, A. Chiti and B. Krause

Excision of titin's cardiac PEVK spring element abolishes PKCalpha-induced increases in myocardial stiffness

B. Hudson, C. Hidalgo, M. Gotthardt and H. Granzier

Adjuvant radioimmunotherapy in experimental colorectal cancer

G. de Jong

Imaging of cellular therapies

M. Srinivas, E. Aarntzen, J. Bulte, W. Oyen, A. Heerschap, I. de Vries and C. Figdor

Development of radiotracers for the determination of the beta-cell mass in vivo

M. Brom, K. Andrałojć, W. Oyen, O. Boerman and M. Gotthardt

Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1$alpha$, IL-1$beta$ or IL-1 receptor type I

L. Joosten, F. De Van Veerdonk, A. Vonk, O. Boerman, M. Keuter, G. Fantuzzi, I. Verschueren, T. Der Van Poll, C. Dinarello, B. Kullberg, J. Der Van Meer and M. Netea